What is the share price of Novyra Pharmachem Limited (NOVYRA) today?
The share price of NOVYRA as on 13th October 2026 is ₹8.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Novyra Pharmachem Limited (NOVYRA) share?
The past returns of Novyra Pharmachem Limited (NOVYRA) share are- Past 1 week: N/A%
- Past 1 month: -16.17%
- Past 3 months: -20.56%
- Past 6 months: -43.03%
- Past 1 year: 31.38%
- Past 3 years: 77.08%
- Past 5 years: 163.16%
What are the peers or stocks similar to Novyra Pharmachem Limited (NOVYRA)?
The peers or stocks similar to Novyra Pharmachem Limited (NOVYRA) include:What is the market cap of Novyra Pharmachem Limited (NOVYRA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Novyra Pharmachem Limited (NOVYRA) is ₹5.38 Cr as of 13th October 2026.What is the 52 week high and low of Novyra Pharmachem Limited (NOVYRA) share?
The 52-week high of Novyra Pharmachem Limited (NOVYRA) is ₹16.55 and the 52-week low is ₹6.79.What is the PE and PB ratio of Novyra Pharmachem Limited (NOVYRA) stock?
The P/E (price-to-earnings) ratio of Novyra Pharmachem Limited (NOVYRA) is -1.00. The P/B (price-to-book) ratio is 8.68.Which sector does Novyra Pharmachem Limited (NOVYRA) belong to?
Novyra Pharmachem Limited (NOVYRA) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Novyra Pharmachem Limited (NOVYRA) shares?
You can directly buy Novyra Pharmachem Limited (NOVYRA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Novyra Pharmachem Limited
NOVYRA Share Price
BSE₹8.502.41% (-0.21)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
NOVYRA Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
NOVYRA Performance & Key Metrics
NOVYRA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -1.00 | 8.68 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.18 | 5.54 | 0.51% |
NOVYRA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
NOVYRA Company Profile
Novyra Pharmachem Limited is an India-based company engaged in pharmaceuticals, chemicals, allied trading/business operations, and also operates segments in real estate and tea estate management.
SUNPHARMA
PE Ratio
36.76
36.76
1Y Return
6.02%
6.02%
Buy Reco %
93.33
93.33
TORNTPHARM
PE Ratio
80.16
80.16
1Y Return
29.01%
29.01%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
22.23
22.23
1Y Return
14.06%
14.06%
Buy Reco %
57.69
57.69
LAURUSLABS
PE Ratio
125.24
125.24
1Y Return
136.02%
136.02%
Buy Reco %
61.54
61.54
CIPLA
PE Ratio
27.60
27.60
1Y Return
15.57%
15.57%
Buy Reco %
62.86
62.86
NOVYRA Forecast
NOVYRA Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
NOVYRA
NOVYRA
Income
Balance Sheet
Cash Flow
Quarterly Normal View
NOVYRA Income Statement
NOVYRA Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.03 | 0.02 | 0.00 | 0.10 | 1.73 | ||||||||||
Operating & Other expenses | 0.02 | 0.00 | 0.00 | 0.01 | 0.06 | 0.03 | 0.00 | 0.02 | 5.44 | 1.74 | ||||||||||
EBITDA | -0.02 | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | 0.02 | -0.02 | -5.34 | -0.01 | ||||||||||
| Depreciation/Amortization | 0.02 | 0.00 | 0.00 | 0.00 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | ||||||||||
| PBIT | -0.04 | 0.00 | 0.00 | -0.01 | -0.04 | -0.01 | 0.01 | -0.03 | -5.35 | -0.01 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -0.04 | 0.00 | 0.00 | -0.01 | -0.04 | -0.01 | 0.01 | -0.03 | -5.35 | -0.01 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Net Income | -0.04 | 0.00 | 0.00 | -0.01 | -0.04 | -0.01 | 0.01 | -0.03 | -5.35 | -0.01 | ||||||||||
| EPS | -0.01 | 0.00 | 0.00 | -0.01 | -0.08 | -0.01 | 0.02 | -0.02 | -8.43 | -0.03 |
NOVYRA Company Updates
NOVYRA Stock Peers
NOVYRA Past Performance & Peer Comparison
NOVYRA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Novyra Pharmachem Limited | -1.00 | 8.68 | — |
| Sun Pharmaceutical Industries Ltd | 36.76 | 5.03 | 0.91% |
| Torrent Pharmaceuticals Ltd | 80.16 | 9.86 | 0.74% |
| Zydus Lifesciences Ltd | 22.23 | 3.79 | 0.09% |
Compare valuation on ScreenerNOVYRA Stock Price Comparison
Compare NOVYRA with any stock or ETFCompare NOVYRA with any stock or ETF
NOVYRA
NOVYRA Holdings
NOVYRA Shareholdings
NOVYRA Promoter Holdings Trend
NOVYRA Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
NOVYRA Institutional Holdings Trend
NOVYRA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
NOVYRA Shareholding Pattern
NOVYRA Shareholding Pattern
NOVYRA Shareholding History
NOVYRA Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing NOVYRA stock
smallcases containing NOVYRA stock
Looks like this stock is not in any smallcase yet.
NOVYRA Events
NOVYRA Events
NOVYRA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
NOVYRA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
NOVYRA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
NOVYRA has not given any dividends in last 5 years
NOVYRA Dividends
NOVYRA Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNOVYRA Stock News & Opinions
NOVYRA Stock News & Opinions
Articles & Videos
Corporate
Corporate
Bansisons Tea Industries schedules AGMBansisons Tea Industries announced that the 39th Annual General Meeting(AGM) of the company will be held on 19 June 2026.
4 months agoCapital Market - Live
Corporate
Corporate
Bansisons Tea Industries revises board meeting dateBansisons Tea Industries has revised the meeting of the Board of Directors which was scheduled to be held on 29 April 2026. The meeting will now be held on 2 May 2026.
5 months agoCapital Market - Live
Corporate
Corporate
Bansisons Tea Industries revises board meeting dateBansisons Tea Industries has revised the meeting of the Board of Directors which was scheduled to be held on 25 April 2026. The meeting will now be held on 29 April 2026.
5 months agoCapital Market - Live
Corporate
Corporate
Bansisons Tea Industries announces board meeting dateBansisons Tea Industries will hold a meeting of the Board of Directors of the Company on 18 April 2026.
6 months agoCapital Market - Live
Corporate
Corporate
Bansisons Tea Industries announces board meeting dateBansisons Tea Industries will hold a meeting of the Board of Directors of the Company on 20 March 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
Bansisons Tea Industries reports standalone net loss of Rs 0.01 crore in the December 2025 quarterNet Loss of Bansisons Tea Industries reported to Rs 0.01 crore in the quarter ended December 2025 as against net loss of Rs 0.01 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Bansisons Tea Industries postpones board meetingBansisons Tea Industries has postponed the meeting of the Board of Directors which was scheduled to be held on 22 January 2026. The meeting will now be held on 26 January 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Bansisons Tea Industries postpones board meetingBansisons Tea Industries has postponed the meeting of the Board of Directors which was scheduled to be held on 22 January 2026. The meeting will now be held on 26 January 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Bansisons Tea Industries to convene board meetingBansisons Tea Industries will hold a meeting of the Board of Directors of the Company on 22 January 2026.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Corporate
Bansisons Tea Industries schedules board meetingBansisons Tea Industries will hold a meeting of the Board of Directors of the Company on 19 November 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -4.36%, vs industry avg of 11.75%
Over the last 5 years, market share stayed at 0%